A crossover clinical trial has raised significant questions about using confocal laser endomicroscopy (CLE) to personalize elimination diets for irritable bowel syndrome (IBS). The technique, which visualizes real-time mucosal reactions when foods are applied directly to the duodenum, had shown promise in earlier uncontrolled studies — but this more rigorous trial tells a different story.

In the study, 33 IBS patients underwent CLE testing, then followed either a targeted diet (avoiding foods that triggered reactions) or a sham diet (avoiding non-reactive foods) for 4 weeks each. The result? Both diets worked about equally well. Roughly 42% of patients improved on the targeted diet vs. 35% on the sham — a difference that wasn't statistically significant.

Key Takeaways:

• 100% of IBS patients showed mucosal alterations on CLE — either at baseline or after food exposure
• Healthy volunteers showed the same 100% reaction rate, suggesting CLE findings aren't IBS-specific
• No changes in gut permeability, mast-cell, or eosinophil activation were detected after food-induced reactions
• The trial was stopped early after an interim analysis showed the targeted diet was unlikely to outperform sham

Why it matters: These findings suggest that CLE-detected mucosal reactions may reflect normal physiology rather than IBS-specific pathology — meaning clinicians should be cautious about using this technique to guide dietary recommendations for IBS patients.